In this review, we present the basic properties, physiological functions, regulation, and pathological alterations of four major classes of K + channels that have been detected channels, which are expressed in smooth muscle of the small-diameter arteries, contribute to the resting membrane potential and basal tone. Kir channel activation has been shown to raise the extracellular K + concentration to 10-15 mM, resulting in vasodilation. Each of K + channels listed above is responsive to a number of vasoconstrictors and vasodilators, which act through protein kinase C (PKC) and protein kinase A (PKA), respectively. Impaired Kv, KATP, and Kir channel functions has been linked to a number of pathological conditions, which may lead to vasoconstriction.
Introduction

K
+ channels contribute to the regulation of the membrane potential in electrically excitable cells, including those found in smooth muscle. Membrane hyperpolarization due to an efflux of K + results from the opening of K + channels in vascular smooth muscle. This effect is followed by the closure of voltage-dependent Ca 2+ channels, leading to a reduction in Ca 2+ entry, and vasodilation (Nelson and Quayle, 1995) . In contrast, inhibition of K + channels function leads to membrane depolarization and vasoconstriction. To date, four distinct types of K + channel have been identified in vascular smooth muscle: voltage-dependent K + (Kv) channels, Ca 2+ -activated K + (BKCa) channels, ATP-sensitive K + (KATP) channels, and inward rectifier K + (Kir) channels (Nelson and Quayle, 1995; Standen and Quayle, 1998) . The fundamental properties of these channels, as well as their responses to various stimuli including vasoconstrictors and vasodilators, and their associated signal pathways have been described in several reports.
In this review, we present a comprehensive summary of the current state of knowledge concerning each of the four major types of K + channel in the vasculature.
Basic properties of K + channels
Voltage-dependent K + channels (Kv channels)
Broad voltage-dependent K + (Kv) channels expression has been detected in vascular smooth muscle cells (e.g., Beech and Bolton, 1989a; Cox and Petrou, 1999) . Kv channels open to allow an efflux of K + in response to depolarization of the membrane potential (Fig. 1A) , resulting in repolarization and a return to the resting membrane potential. Small-scale depolarization in vascular smooth muscle cells leads to an influx of Ca 2+ through L-type Ca 2+ channels and activation of the contractile machinery. Taken together, this indicates that Kv channels function to limit membrane depolarization and maintain resting vascular tone (Nelson and Quayle, 1995; Sobey, 2001; Korovkina and England, 2002) . The Kv channel inactivation results from sustained depolarization. Compared to the process of activation, Kv channel inactivation is relatively slow and involves an initial peak in the Kv current due to voltage-dependent activation followed by a drop in the current due to voltagedependent inactivation (Nelson and Quayle, 1995) . Steady-state Kv channel activation can be described using the Boltzmann equation: y = 1 / {1 + exp (-(V -V1/2) / k)}, where k is the slope factor, V is the test potential, and V1/2 is the voltage require for half-maximal conductance (Park et al., 2005a (Park et al., , 2005b . Using this equation, Kv channels in arterial smooth muscle cells have been shown to have k-values between 9 and 11 and to display half-maximal activation at voltages between -6 to -15 mV (Volk et al., 1991; Robertson and Nelson, 1994; Nelson and Quayle, 1995; Park et al., 2005a Park et al., , 2005b . Similarly, Kv channel inactivation can be described using another Boltzmann equation: y = 1 / {1 + exp ((V -V1/2) / κ)} where V is the preconditioning potential, V1/2 is the half-inactivation potential, and κ is the slope value (Park et al., 2005a (Park et al., , 2005b . Based on these definitions, k-values between 5 and 11 and half-maximal inactivation values between -25 to -45 mV have been recorded for Kv channels (Volk et al., 1991; Robertson and Nelson, 1994; Nelson and Quayle, 1995; Park et al., 2005a Park et al., , 2005b . Divergent results have been obtained concerning the single-channel conductance of the Kv channels in vascular smooth muscle cells. For example, single-channel conductances of 5 and 8 pS were recorded in rabbit portal vein using physiological concentration of K + (i.e., between 4 and 6 mM) (Beech and Bolton, 1989b) , whereas a conductance of 6.5 pS was obtained using pig portal vein (Karle et al., 1998) . Moreover, conductances of 4.4, 7.3, and 5.5 pS have been reported for rabbit cerebral, coronary, and basilar arteries, respectively (Volk and Shibata, 1993; Robertson and Nelson, 1994; Nelson and Quayle, 2005 Gelband and Hume, 1992; Ishikawa et al., 1993; Nelson and Quayle, 1995) .
The various constituents of the Kv current have been identified, and the Kv channels present in vascular smooth muscle have been divided into groups based on their voltagedependence and pharmacological data. To date, more than 30 genes encoding several subfamilies of Kv α-subunits are currently recognized (Korovkina and England, 2002) .
Structurally, α-subunits in Kv channels have cytoplasmic N-and C-termini and contain pore- forming six transmembrane domains (S1-S6) with an S4 voltage-sensing transmembrane domain (Korovkina and England, 2002) . Each α-subunit is associated with ancillary β-subunits, which influences the characteristics of the channel (Bahring et al., 2001 ). Many Kv channel have similar kinetics and pharmacological properties; thus, it can be difficult to determine which Kv channel genes are being expressed in a particular cell. However, it has been shown that the Kv1.5, Kv2.2, and Kvβ4 subunits are expressed in canine vascular smooth muscle cells (Horowitz, 1997) , whereas the Kv1.1, Kv1.2, Kv1.4, Kv1.5 Kv1.6, Kv2.1, and Kv9.3 subunits, as well as the Kvβ1, Kvβ2, and Kvβ subunits are expressed in smooth muscle cells of the pulmonary artery (Yuan et al., 1998; Standen and Quayle, 1998) .
The compound 4-Aminopyridine (4-AP) has been used in many studies of vascular smooth muscle as a Kv channel blocker in order to separate the Kv current from BKCa current, which is also activated by membrane depolarization (Okabe et al., 1987; Smirnov and Aaronson, 1992; Nelson and Quayle, 1995) . The concentration of 4-AP needed for half-maximal inhibition of Kv channels function in various types of vascular smooth muscle has been shown to be between 0.3 and 1.1 mM (Okabe et al., 1987; Smirnov and Aaronson, 1992; Gelband and Hume, 1992) . Though 4-AP has no effect on BKCa or Kir channels at these concentrations, inhibition of KATP currents has been reported (Beech and Bolton, 1989c; Quayle et al., 1993; Nelson and Quayle, 1995) . Of the various compounds known to inhibit K + channel function, including Ba 2+ (50 µM for Kir channel), glibenclamide (10 µM for KATP channel), and iberiotoxin (100 nM for BKCa channel), none has been shown to alter the Kv current at its working concentration (Nelson and Quayle, 1995) .
Ca
2+ -activated K + channels (BKCa channels)
Large-conductance (200 ~ 250 pS) Ca 2+ -activated K + (BKCa) channels are a persistent feature of vascular smooth muscle cells (Fig. 1B) . BKCa channels, which are activated by changes in the intracellular Ca 2+ concentration and membrane depolarization, are believed to contribute to the maintenance of the membrane potential in small myogenic vessels (Nelson and Quayle, 1995; Waldron and Cole, 1999; Park et al., 2007a) . The efflux of K + that results from BKCa channel activation can be used to counteract pressure-or chemical-induced depolarization and vasoconstriction (Brayden and Nelson, 1992; Tanaka et al., 2004) . Similar to Kv channels, BKCa channels are comprised of a pore-forming α-subunit and a regulatory β-subunit (Knaus et al., 1994; Toro et al., 1998; Tanaka et al., 2004) . α-Subunits contain six transmembrane-spanning domains (S1-S6), including a voltage sensor (S4), which form the pore (Nelson and Quayle, 1995) . However, the α-subunits, which are produced from a single gene (slo) by alternative splicing (McCobb et al., 1995; Standen and Quayle, 1998; Waldron and Cole, 1999) , contain an additional seventh transmembrane region (S0) at exoplasmic NH2 terminus (Wallner et al., 1996; Tanaka et al., 2004) . In addition, there are four β-subunit isoforms (β1-4), each with two transmembrane domains, which may be associated with the α-subunits in a 1:1 ratio (Wallner et al., 1995) . Of the four isoforms, β1 subunit is the predominant isoform in vascular smooth muscle (Jiang et al., 1999; Tanaka et al., 2004) . The major function of the β-subunits is to enhance the Ca 2+ sensitivity of the channel (Meera et al., 1996; Tanaka et al., 1997; Waldron and Cole, 1999) .
BKCa channel may be blocked by external TEA, iberiotoxin, and charybdotoxin at halfinhibition value of 200 µM, < 10 nM, and ~ 10 nM, respectively (Miller et al., 1985; Langton et al., 1991; Giangiacomo et al., 1992; Nelson and Quayle, 1995) . Of these blockers, iberiotoxin is the most selective blocker; it has a very low half-inhibition value and its value is ineffective against the other types of K + channels (Wallner et al., 1995) . Charybdotoxin has been used as a selective BKCa channel blocker; however, it also affects Kv channels as well as intermediateconductance Ca 2+ -activated K + channels (Carl et al., 1991; Grebremedhin et al., 1996; Waldron and Cole, 1999) . BKCa channels are not affected by glibenclamide, Ba 2+ or apamin, which blocks low-conductance Ca 2+ -activated K + channels, at their working concentrations (Nelson and Quayle, 1995) . Both NS-004 and NS-1619 have been used to stimulate BKCa channels in smooth muscle (Hu and Kim, 1996; Edwards et al., 1994) , but they are of limited value given their nonspecific inhibitory effects on L-type Ca 2+ channels (Sargent et al., 1993; Sheldon et al., 1997; Park et al., 2007b) . Given this information, one should exercise caution when using these types of agents to study BKCa channels.
ATP-sensitive K + channels (KATP channels)
ATP-sensitive K + (KATP) channels have been first identified by in cardiac muscle and then, they have been found in various cells including vascular smooth muscle ( Fig. 1C ) (Noma, 1983; Nelson and Quayle, 1995) . It has been shown both in vitro and in vivo that a block in KATP channels leads to vasoconstriction and membrane depolarization in various types of vascular smooth muscle (Nelson et al., 1990; Nakashima and Vanhoutte, 1995, Quayle et al., 1997; Teramoto, 2006) . KATP channel activation is closely associated with several pathophysiological responses, including systemic arterial dilation during hypoxia (Daut et al., 1990; Brayden, 2002) , reactive hyperemia in coronary and cerebral circulation (Kanatsuka et al., 1992; Bari et al., 1998; Brayden, 2002) , and acidosis-and endotoxic shock-induced vasodilation (Landry and Oliver, 1992; Ishizaka and Kuo, 1996; Kinoshita and Katusic, 1997) . Moreover, the inhibition of KATP channels leads to impaired coronary and cerebral autoregulation (Narishige et al., 1993; Hong et al., 1994; Nelson and Quayle, 1995) .
The single-channel conductances reported for KATP channels in vascular smooth muscle vary considerably; however, they clearly fall into two distinct categories: small/medium conductances and large conductances (Quayle et al., 1997) . Values between 7 and 15 pS have pS have been identified at symmetric high K + in arterial smooth muscle cells (Kajioka et al., 1991; Beech et al., 1993; Kamouchi and Kitamura, 1994; Dart and Standen, 1995; Nelson and Quayle, 1995; Zhang and Bolton, 1995; Teramoto and Brading, 1996; Quayle et al., 1997) . The KATP channels with larger unitary conductances between 130 and 260 pS in high K + have been recorded in smooth muscle cells from aorta, renal arteriole, mesenteric artery, and rat tail artery (Standen et al., 1989; Lorenz et al., 1992; Furspan and Webb, 1993; Matzno et al., 1995; Quayle et al., 1997) . The reason for the broad range of single-channel conductances among KATP is unknown; However, it indicates that channel conductance can be altered depending on the experimental conditions (e.g., the recording solution, digestive enzyme, and excised patch configuration) and/or that multiple isoforms of the channel exist (Nelson and Quayle, 1995) .
KATP channels are hetero-octameric complexes containing four pore-forming, inwardly rectifying channel subunits (Kir6.1 or Kir6.2), together with four sulphonylurea receptors (SURs), which are ATP-binding cassette (ABC) family proteins (Babenko et al., 1998; Standen and Quayle, 1998; Teramoto, 2006) . The molecular diversity that exists between species and tissues in terms of their KATP channel is magnified by the presence of multiple isoforms of SUR (SUR1, SUR2A, and SUR2B) (Brayden, 2002) . KATP channels in vascular smooth muscle most likely contain Kir6.X/SUR2B, as co-expression of SUR2B with Kir6.1 or Kir6.2 has been shown to produce channels with the properties of native KATP channels in smooth muscle (Yamada et al., 1997; Koh et al., 1998; Standen and Quayle, 1998; Cui et al., 2002) .
KATP channels in smooth muscle are known to be inhibited by anti-diabetic sulphonylurea drugs, such as glibenclamide and tolbutamide (Fig. 1C) . Glibenclamide is the most frequently used inhibitor of KATP channels in studies of arterial smooth muscle, with a half-inhibition value between 20 and 200 nM (Beech et al., 1993; Xu and Lee, 1994; Nelson and Quayle, 1995; Quayle et al., 1995) . Tolbutamide, with a half-inhibition value of 350 µM in smooth muscle, is considerably less effective than glibenclamide as a hypoglycemic agent (Quayle et al., 1995) . U-37883A and 5-hydroxydecanoate are selective inhibitors of non-vascular KATP channels with halfinhibition values of 0.26 µM and 0.16 µM, respectively (Notsu et al., 1992; Guillemare et al., 1994; Quayle et al., 1997) . External Ba 2+ also could be act as an inhibitor of KATP channels in smooth muscle, with a half-inhibition value of 100 µM at -80 mV (Nelson and Quayle, 1995; Quayle et al., 1988; Bonev and Nelson, 1993) . The KATP channels are not affected by iberiotoxin and are less sensitive to TEA, with a half-inhibition value of 7 mM in both smooth and skeletal muscle (Davies et al., 1989; Nelson and Quayle, 1995; Quayle et al., 1995) . Numerous synthetic K + channel activators belonging to several distinct classes have been produced, including cromakalim, levcromakalim, nicorandil, pinacidil, minoxidil, diazoxide, and BRL-55834 (Quayle et al., 1997) . The vasodilation induced by these agents can be successfully blocked by glibenclamide; thus, they are believed to hyperpolarize the cells in vascular smooth muscle by targeting KATP channels. However, other K + channel blockers, such as iberiotoxin, apamin, or low concentrations of TEA are ineffective to KATP channels (Brayden, 2002) .
Inward rectifier K + channels (Kir channels)
Inward rectifier K + (Kir) channels are abundant in the smooth muscle of small-diameter resistance vessels (Fig. 1D ) (Knot et al., 1996; Quayle et al., 1996; Park et al., 2006a) . Though the exact function of Kir channels in vascular smooth muscle is still incomplete, there are two basic possibilities. First, Kir channels contribute to the resting membrane potential and resting tone in small-diameter vascular smooth muscle. This hypothesis is supported by studies showing the constriction of small-diameter coronary and cerebral arteries at resting tone in response to Ba 2+ , a specific inhibitor of Kir channels (Park et al., 2007c , Park et al., 2007d .
Second, Kir channel activation in response to moderate increases in the extracellular K + concentration (to 10-15 mM) may cause vasodilation. Evidence for this hypothesis comes from the fact that vasodilation can be prevented by Ba 2+ but not by removal of the endothelium or by inhibitors of the other K + channels (Nelson and Quayle, 1995; Knot et al., 1996; Chrissobolis et al., 2000; Zaritsky et al., 2000; Eckman and Nelson, 2001; Rivers et al., 2001; Park et al., 2007d) .
The Kir channels in vascular smooth muscle cells mediate inward currents at membrane potentials that are negative relative to the EK and small outward currents at membrane potentials that are positive relative to the EK (Edwards and Hirst, 1988; Edwards et al., 1988; Quayle et al., 1993) . Given that the membrane potential of vascular smooth muscle is normally positive relative to the EK, a physiological role for the inward rectifier channel requires outward current through the channel (Robertson et al., 1996) . The measured outward current is on the order of a few picoamperes, possibly as a result of internal Mg 2+ or internal polyamine blocking (Matsuda et al., 1987 , Nichols et al., 1996 Xu et al., 1999) . Only a few papers have addressed the single-channel properties of Kir channel in vascular smooth muscle. The first report of single channel currents corresponding to Kir (Kir2.1) channel, a 21 pS single-channel conductance in small-diameter coronary arteries, was made by our group (Park et al., 2005c) . Similarly, a conductance of 20 pS has been reported for Kir2.1 channels in human pulmonary artery smooth muscle cells (Tennant et al., 2006) . However, additional studies are required to produce a more detailed picture of the single channel conductance of Kir channels in vascular smooth muscle cells.
Kir channels are tetramers whose subunits, each of which contains only two transmembrane domains, are encoded by members of the Kir gene family (Standen and Quayle, 1998; Kubo et al., 2005) . Channels formed from subunits encoded by the Kir2.0 gene subfamily exhibit properties that are typical of native strong inward rectifiers. Moreover, their biophysical properties in coronary, cerebral, basilar arterial smooth muscle correspond closely to those reported for Kir2.1 channels expressed in a heterologous system, suggesting that Kir2.1, but not Kir2.2 or Kir2.3, is expressed in vascular smooth muscle (Standen and Quayle, 1998; Bradley et al., 1999; Chrissobolis et al., 2000; Park et al., 2005c) . Furthermore, targeted gene disruption of Kir2.1 (Kir2.1 -/-) completely abrogated the Kir currents, and arteries from Kir2.1 -/-animals did not dilate in response to elevated K + to 15 mM (Zaritsky et al., 2000) . However, Wu et al. (2007) suggested that the Kir channels in cerebral arteries contain both Kir2.1 and Kir2.2. In addition, Kir2.1 and Kir2.4 expression has been detected in cultured human pulmonary arterial smooth muscle cells (Tennant et al., 2006) . Additional studies are required to characterize the expression and function of each Kir subtypes. Ba 2+ blocks the Kir currents in vascular smooth muscle cells in a voltage-dependent fashion.
In fact, the half-inhibition values for the inhibition mediated by Ba 2+ , which has been shown to be 2.1 µM and 2.2 µM at -60 mV in coronary and cerebral arteries, respectively, increases exponentially with hyperpolarization (Quayle et al., 1993; Robertson et al., 1996) . However, Ba 2+ is much less effective against KATP channels (Kd, 200 µM at -60 mV), BKCa channels (Kd>10 mM), and Kv channels (Kd>1 mM) (Nelson and Quayle, 1995; Robertson et al., 1996) .
Therefore, at concentrations below 50 µM, Ba 2+ is a selective blocker of Kir channels in vascular smooth muscle. Cs + , which acts from outside the cell, also inhibits Kir currents in vascular smooth muscle with a Kd of 2.9 mM at -60 mV (Robertson et al., 1996; Quayle et al., 1997 et al., 1996) .
Modulation of K + channels by vasoactive substances
Effect of vasoconstrictors on K + channels: role of PKC
A number of vasoconstrictors inhibit K + channel activity, which contributes to membrane depolarization. Generally, vasoconstriction is initiated at membrane receptors that are coupled through a GTP-binding protein (Gq) to phospholipases, which generate the second messengers diacylglycerol and inositol 1,4,5-triphosphate (IP3), which activate protein kinase C (PKC) (Fig. 2) (Standen and Quayle, 1998) . Several PKC isoforms, including α, β, ε and ζ have been identified in vascular smooth muscle according to their Ca 2+ -dependence (Dixon et al., 1994; Lee and Severson, 1994) . Classic PKCs (α and β) activation requires Ca 2+ , diacylglycerol, and phosphatidylserine; in comparison, the novel PKC (ε) requires diacylglycerol and phosphatidylserine, but not Ca 2+ , and the atypical PKC (ζ) is activated by phosphatidylserine alone (Park et al., 2006b ).
Endothelin and angiotensin have shown to inhibit Kv currents via Ca 2+ -independent PKCε activation (Clement-Chomienne et al., 1996; Shimoda et al., 1998; Hayabuchi et al., 2001a) .
More recently, Kv channel inhibition by thromboxane A2 reportedly involves PKCζ (Cogolludo et al., 2003; Crozatier, 2006) . Despite the PKC-independent inhibition of BKCa channels by angiotensin in coronary arteries (Toro et al., 1990; Minami et al., 1995) , most recent data indicate that PKC phosphorylation inhibits BKCa channels in vascular smooth muscle (Crozatier, 2006; Ledoux et al., 2006) . However, the precise role of each PKC isoform remains to be determined. In vascular smooth muscle, several vasoconstrictors such as angiotensin, endothelin, vasopressin, noradrenaline, histamine, serotonin, and neuropeptide Y inhibit KATP channels function via PKC activation (primarily Ca 2+ -independent PKCε) (Wakatsuki et al., 1992; Bonev and Nelson, 1996; Tanaka et al., 1997; Hayabuchi et al., 2001b; Park et al., 2005d) . The inhibitory effect of these compounds on Kir channels has not been examined as extensive as their effects on other K + channels. Recent papers have shown that endothelin and angiotensin have been shown to inhibit Kir channel function; however, this inhibition is closely associated with Ca 2+ -dependent PKCα activation (Park et al., 2005c (Park et al., , 2006b . Consistent with these findings, it has been suggested that microvessels, have Kir channels, express relatively high levels of PKCα and low levels of PKCε (Collins et al., 1992; Dessy et al., 2000) .
Effect of vasodilators on K + channels: role of PKA and PKG
A number of vasodilators including calcitonin gene-related peptide, β-adrenergic agonists, vasoactive intestinal peptide, and adenosine, activate adenylyl cyclase, thereby increasing the intracellular concentration of cAMP, which activates cAMP-dependent protein kinase (PKA) (Standen and Quayle, 1998) . Several types of vascular K + channels are activated in this mechanism (Fig. 2) . The KATP channels in vascular smooth muscle are responsive to many of the vasodilators that function through PKA, including calcitonin gene-related peptide, adenosine, and isoprenaline (Kleppisch and Nelson, 1995; Quayle et al., 1997; Wellman et al., 1998) . BKCa channels are also activated by vasodilators coupled to PKA. However, most studies have addressed activation by the β-adrenoceptor (Sadoshima et al., 1988; Song and Simard, 1995; Standen and Quayle, 1998) . Though the regulation of Kv channels by vasodilators has been largely ignored, β-adrenoceptor stimulation has been shown to activate Kv currents through PKA in rabbit vascular smooth muscle cells (Aiello et al., 1995; Standen and Quayle, 1998) . More recently, it was suggested that the potent vasodilator, adenosine also activates Kir currents through PKA (Park et al., 2005e; Son et al., 2005) . Kir channels, like other K + channels, may also be modulated by other important vasodilators; additional studies are required to solve this issue. Some vasodilators act through guanylyl cyclase, leading first to an increase in intracellular cGMP, then consequently activates cGMP-dependent protein kinase (PKG) (Standen and Quayle, 1998) . The activation of PKG by nitric oxide or nitrovasodilators results in the activation of BKCa channels in isolated smooth muscle cells from coronary and cerebral arteries (Williams et al., 1988; Robertson et al., 1993) . There is also some evidence that PKG can activate the KATP channels in certain types of vascular smooth muscle. Atrial natriuretic factor and isosorbide dinitrate increase the intracellular cGMP level in cultured vascular smooth muscle cells, leading to the activation of individual KATP channels (Miyoshi et al., 1994; Kubo et al., 1994; Nelson and Quayle, 1995) . Furthermore, nitric oxide induces glibenclamide-sensitive K + current in vascular smooth muscle, suggesting that either a rise in the level of cGMP or stimulation of PKG leads to KATP channel activation (Fig. 2) (Murphy and Brayden, 1995; Nelson and Quayle, 1995) .
Alteration of K + channels in pathological conditions
Impaired K + channel function in vascular smooth muscle cells has been detected in various pathological conditions including hypertension, diabetes, ischemia/reperfusion, and brain injury (Fig. 3) . For Kv channels, several studies have reported reduced Kv channel function in hypertension and hypertrophy (Martens and Gelband, 1996; Kim et al., 2001; Wellman et al., 2001) . Pathological alterations of KATP channels are relatively well characterized in diabetes, ischemia, and hypertension; these studies clearly demonstrated impaired KATP channel function and altered gene expression in various arteries (e.g., Mayhan, 1994; Bari et al., 1996; Ghosh et al., 2004) . In spite of the fact that BKCa channel function is believed to be enhanced by such pathological conditions as hypertension (Liu et al., 1998) , some reports suggest that BKCa channel function is reportedly diminished in hypertrophy, (Kim et al., 2003) or is unaffected by ischemia (Bari et al., 1997) . Recent evidence suggests that Kir channels are also affected by hypertension, ischemia, hypertrophy, and diabetes (McCarron and Halpern, 1990; Marrelli et al., 1998; Mayhan et al., 2004; Park et al., 2007c) , but additional studies are necessary to establish a mechanism.
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